Revenue - Summary of Revenue by Category (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 44,747	$ 66,940	$ 155,610	$ 207,112
PGS
Disaggregation of Revenue [Line Items]
Revenue	35,076	42,599	111,707	131,616
PGS | Point in Time
Disaggregation of Revenue [Line Items]
Revenue	29,241	37,499	95,202	117,300
PGS | Over Time
Disaggregation of Revenue [Line Items]
Revenue	5,835	5,100	16,505	14,316
Telehealth
Disaggregation of Revenue [Line Items]
Revenue	7,822	11,043	27,401	34,595
Telehealth | Point in Time
Disaggregation of Revenue [Line Items]
Revenue	5,894	8,592	21,051	27,124
Telehealth | Over Time
Disaggregation of Revenue [Line Items]
Revenue	1,928	2,451	6,350	7,471
Consumer services
Disaggregation of Revenue [Line Items]
Revenue	42,898	53,642	139,108	166,211
Consumer services | Point in Time
Disaggregation of Revenue [Line Items]
Revenue	35,135	46,091	116,253	144,424
Consumer services | Over Time
Disaggregation of Revenue [Line Items]
Revenue	7,763	7,551	22,855	21,787
Research services
Disaggregation of Revenue [Line Items]
Revenue	1,849	13,298	16,502	40,901
Research services | Point in Time
Disaggregation of Revenue [Line Items]
Revenue	1,506	0	3,859	0
Research services | Over Time
Disaggregation of Revenue [Line Items]
Revenue	343	13,298	12,643	40,901
Service
Disaggregation of Revenue [Line Items]
Revenue	44,747	66,940	155,610	207,112
Service | Point in Time
Disaggregation of Revenue [Line Items]
Revenue	36,641	46,091	120,112	144,424
Service | Over Time
Disaggregation of Revenue [Line Items]
Revenue	8,106	20,849	35,498	62,688
Therapeutics
Disaggregation of Revenue [Line Items]
Revenue	$ 0	$ 0	$ 0	$ 0
Product Concentration Risk | Revenue | PGS
Disaggregation of Revenue [Line Items]
Concentration risk percentage	78.00%	64.00%	72.00%	63.00%
Product Concentration Risk | Revenue | PGS | Point in Time
Disaggregation of Revenue [Line Items]
Concentration risk percentage	65.00%	56.00%	61.00%	57.00%
Product Concentration Risk | Revenue | PGS | Over Time
Disaggregation of Revenue [Line Items]
Concentration risk percentage	13.00%	7.00%	11.00%	7.00%
Product Concentration Risk | Revenue | Telehealth
Disaggregation of Revenue [Line Items]
Concentration risk percentage	18.00%	16.00%	17.00%	17.00%
Product Concentration Risk | Revenue | Telehealth | Point in Time
Disaggregation of Revenue [Line Items]
Concentration risk percentage	13.00%	13.00%	14.00%	13.00%
Product Concentration Risk | Revenue | Telehealth | Over Time
Disaggregation of Revenue [Line Items]
Concentration risk percentage	4.00%	4.00%	4.00%	3.00%
Product Concentration Risk | Revenue | Consumer services
Disaggregation of Revenue [Line Items]
Concentration risk percentage	96.00%	80.00%	89.00%	80.00%
Product Concentration Risk | Revenue | Consumer services | Point in Time
Disaggregation of Revenue [Line Items]
Concentration risk percentage	78.00%	69.00%	75.00%	70.00%
Product Concentration Risk | Revenue | Consumer services | Over Time
Disaggregation of Revenue [Line Items]
Concentration risk percentage	17.00%	11.00%	15.00%	10.00%
Product Concentration Risk | Revenue | Research services
Disaggregation of Revenue [Line Items]
Concentration risk percentage	4.00%	20.00%	11.00%	20.00%
Product Concentration Risk | Revenue | Research services | Point in Time
Disaggregation of Revenue [Line Items]
Concentration risk percentage	3.00%	0.00%	2.00%	0.00%
Product Concentration Risk | Revenue | Research services | Over Time
Disaggregation of Revenue [Line Items]
Concentration risk percentage	1.00%	20.00%	8.00%	20.00%
Product Concentration Risk | Revenue | Service
Disaggregation of Revenue [Line Items]
Concentration risk percentage	100.00%	100.00%	100.00%	100.00%
Product Concentration Risk | Revenue | Service | Point in Time
Disaggregation of Revenue [Line Items]
Concentration risk percentage	81.00%	69.00%	77.00%	70.00%
Product Concentration Risk | Revenue | Service | Over Time
Disaggregation of Revenue [Line Items]
Concentration risk percentage	18.00%	31.00%	23.00%	30.00%